Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

The National Agency for Food and Drug Administration and Control (NAFDAC) on Friday destroyed fake, counterfeit and ...

Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...

Find insight on BioNTech, PharmAla Biotech, Dentalcorp Holding and more in the latest Market Talks covering the Health Care ...

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

Pharmacists have called for immediate action against the rampant illegal drug market, labeling those involved as "merchants ...

Alnylam Pharmaceuticals' shares rose about 7% before the bell on Friday following U.S. approval for its drug for a rare and deadly heart disease, securing an entry into a market dominated by Pfizer's ...

Telix Pharmaceuticals' said its new drug application in the U.S. for an imaging agent received regulatory approval. The Melbrourne, Australia-based biopharmaceutical company said Friday that the Food ...

The National Agency for Food and Drug Administration and Control, NAFDAC, has burnt substandard drugs contained in over 100 ...

The United States possesses numerous trade tools and diplomatic levers to compel foreign countries to pay prices that reflect ...

Nanomi B.V., a Dutch subsidiary of the global pharma major Lupin, today announced that it has won the prestigious CMO Award for Life Science Leadership in Drug Delivery, during the Drug, Chemical and ...

The massive PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are ...